Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.

Lancet Digit Health · 2021 · PMC7834915 · PMID 33342753

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

41 We observed one nominally significant meta-analysis difference: users of ACEI combination therapy had a lower risk of COVID-19 diagnosis when compared with users of ARB combination therapy.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.